Drug intelligence / Profile preview

[99mTc]Tc-EDDA-KL01127

Development stage
Preclinical
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[99mTc]Tc-EDDA-KL01127 is an experimental **PSMA-targeted technetium-99m radiopharmaceutical** being developed as a **SPECT imaging tracer** for **prostate cancer**. It is a Lys-urea-Aad pharmacophore-derived small-molecule ligand labeled with technetium-99m using an EDDA-based chelation system, designed to bind **prostate-specific membrane antigen** on prostate cancer cells and enable tumor visualization after intravenous administration. In the cited preclinical study, it showed successful imaging of LNCaP xenografts, predominantly renal clearance, and lower off-target uptake in spleen and salivary glands with improved tumor-to-background contrast relative to [99mTc]Tc-EDDA/HYNIC-iPSMA, supporting potential clinical translation as a PSMA SPECT diagnostic agent.

Other names
technetium Tc 99m EDDA-KL01127
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on [99mTc]Tc-EDDA-KL01127.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [99mTc]Tc-EDDA-KL01127.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call